Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib. [electronic resource]
Producer: 20180326Description: 36161-36170 p. digitalISSN:- 1949-2553
- Aged
- Antineoplastic Agents -- therapeutic use
- Biomarkers -- metabolism
- Carcinoma, Hepatocellular -- diagnosis
- Female
- Follow-Up Studies
- Humans
- Inflammation -- diagnosis
- Liver Neoplasms -- diagnosis
- Lymphocytes -- immunology
- Male
- Middle Aged
- Neoplasm Staging
- Neutrophils -- immunology
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Predictive Value of Tests
- Prognosis
- Retrospective Studies
- Risk
- Sorafenib
- Survival Analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.